Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples